临床决策支持旨在加快分离和时间到含的IV液体在ED的儿童严重代谢条件的ED
Swaminathan Kandaswamy1, Shabnam Jain1,2, Dwight Diaz Chambers3
1Department of Pediatrics, Emory University, Atlanta, Georgia, United States.
Applied clinical informatics
|September 11, 2025
概括
对患有代谢疾病的儿童而言,一项新的临床决策支持工具提高了分拣准确度,并减少了对乳糖液的时间. 虽然它不会影响ICU入院,但它强调了以用户为中心的设计在儿科护理中的价值.
科学领域:
- 儿科急救医学 儿科急救医学
- 临床决策支持系统 临床决策支持系统
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 患有代谢疾病的儿童面临快速失补偿的高风险.
- 有效的临床决策支持 (CDS) 对于及时干预至关重要.
- 以人为中心的设计原则对于成功实施CDS至关重要.
研究的目的:
- 描述儿童代谢疾病的CDS以人为中心的设计.
- 评估CDS对护理流程和患者结果的影响.
- 为未来的CDS开发分享实施见解.
主要方法:
- 与儿科遗传学专家合作设计CDS.
- 与急诊室 (ED) 护士和提供者进行形成性可用性测试.
- 对预干预和后干预数据进行比较,对分拣,警报接受,订单集使用和临床结果进行比较.
主要成果:
- 提供者警报的接受率为39%.
- 护士分类敏度 (紧急严重性指数<3) 从84%增加到98%.
- 从房间隔离到施用乳糖液的时间显著减少 (101到82分钟).
结论:
- 以用户为中心的CDS设计提高了分拣的适当性,并减少了儿科代谢紧急情况的关键液体的时间.
- CDS并没有显著改变ICU入院率或停留时间.
- 可用性测试和以临床医生为中心的设计是有效地将CDS整合到儿科护理中的关键.
相关概念视频
Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
SBAR II: Application of SBAR
5.7K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Cardiopulmonary Resuscitation IV: Pharmacological Management
679
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
679
Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258


